Longitudinal Antibody Responses to SARS-CoV-2 Infection in Children: Impact of Age, Vaccines and Symptoms
The majority of children experience severe acute respiratory syndrome coronavirus-2 infection as a mild infection. In this longitudinal single-center study of children infected early in the pandemic and managed as outpatients, we assess the impact of age, vaccination, recurrent infection and initial symptoms on severe acute respiratory syndrome coronavirus-2-specific antibody responses over time.
Authors
- Kristin Moffitt (ORCID: https://orcid.org/0000-0003-4581-7199)
- Lorrie L. He (ORCID: https://orcid.org/0000-0002-8438-6603)
- Peijun Ma (ORCID: https://orcid.org/0000-0002-7670-7016)
- Hannah H. Laibinis
- Deborah T. Hung (ORCID: https://orcid.org/0000-0003-4262-0673)
- Sunil Ekanath Jadhav (ORCID: https://orcid.org/0000-0001-6948-2237)
- P. Chen
Institutions
- Broad Institute (US)
- Boston Children's Hospital (US)
- Apple (Israel) (IL)
- St. Jude Children's Research Hospital (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1097/inf.0000000000004949
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00